Cancer vaccine russia: The country’s Federal Medical

The country’s Federal Medical and Biological Agency (FMBA) has announced that its mRNA-based cancer vaccine , Enteromix, has shown 100% success in preclinical trials. The vaccine not only proved to be safe but also showed powerful tumour-fighting abilities. A growing buzz surrounds the surprising link between the COVID-19 vaccine ’s cancer -prevention potential and Russia ’s newly announced cancer vaccine . Russia has declared its readiness to use Enteromix as a personalised cancer vaccine for clinical applications, after successful development through mRNA technology similar to COVID-19 vaccines. Russian Mrna Vaccine Cancer : Enteromix, has achieved 100% efficacy and safety in early clinical trials targeting colorectal cancer . Developed using COVID-19 vaccine technology, it's now awaiting ...